UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13D

 

Under the Securities Exchange Act of 1934

 

 

Skinvisible,
Inc.

(Name of Issuer)

 

COMMON
STOCK, $0.001 PER SHARE PAR VALUE

(Title of Class of Securities)

 

830703
104

(CUSIP Number)

 

Doreen McMorran

Skinvisible, Inc.

6320 S.
Sandhill Road Suite 10, Las Vegas, Nevada 89120

(Name, Address and Telephone Number of Person
Authorized to

Receive Notices and Communications)

 

 

December
31, 2010

(Date of Event Which Requires Filing of this
Statement)

 

 

If the filing person has previously filed a statement on Schedule
13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), Rule
13d-1(f) or Rule 13d-1(g), check the following box.[ ]

 


    
 
    
1
    



*The remainder of this cover page shall be
filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent
amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of
this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934
("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions
of the Act (however, see the Notes).	

 



    1.
    Names of Reporting Persons: 
    Doreen McMorran

     
     

     
     

    2.
     Check the Appropriate Box if a Member of a Group (See Instructions)

     
    (a)   [ ]

     
    (b)   [ ]

     
     

    3.
    SEC Use Only:

     
     

    4.
    Source of Funds (See Instruction):
    PF

     
     

    5.
     Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e): [ ]

     
     

     
     

    6.
     Citizenship or Place of Organization:	 
    Canadian

     
     

    Number of Shares Beneficially by Owned by Each Reporting Person With:

     
     

    7.
    Sole Voting Power: 
     22,944,266 SHARES

     
     
     

    8.
    Shared Voting Power: 
    N/A

     
     
     

    9.
    Sole Dispositive Power: 
    22,944,266 SHARES

     
     
     

    10.
    Shared Dispositive Power: 
    N/A

     
     
     

     
     
     

    11.
     Aggregate Amount Beneficially Owned by Each Reporting Person: 22,944,266 SHARES

     
     
     

     
     
     

    12.
     Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions): [ ]

     
     
     

     
     
     

    13.
     Percent of Class Represented by Amount in Row (11): 23.9%

     
     
     

     
     
     

    14.
     Type of Reporting Person (See Instructions): IN

     
     

     
     
     
     


    
 
    
2
    



ITEM 1.	SECURITY AND ISSUER.

 

This Statement on Schedule 13D relates to the
common stock, par value $0.001 per share (the “Shares”), of Skinvisible, Inc., a Nevada Corporation (the "Issuer"),
and is being filed by Doreen McMorran (the “Reporting Person”). The Issuer's current principal executive offices are
located at 6320 S. Sandhill Road Suite 10, Las Vegas, Nevada 89120.

 

ITEM 2.	IDENTITY AND BACKGROUND

 

(a) through (c) and (f). This Statement is
being filed by Doreen McMorran (the “Reporting Person”). The business address of the Reporting Person is 6320 S. Sandhill
Road Suite 10, Las Vegas, Nevada 89120. The Reporting Person is currently employed by the Issuer as the head of Business Development.
The Reporting Person is a citizen of Canada.

 

(d) and (e). During the previous five (5) years,
the Reporting Person (i) has not been convicted in any criminal proceeding (excluding traffic violations or similar misdemeanors)
and (ii) has not been party to a civil proceeding of any of a judicial or administrative body of competent jurisdiction such that,
as a result of such proceeding, was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting
or mandating activity subject to, federal or state securities laws or finding any violation with respect to such laws.

 

ITEM 3. 	SOURCE AND AMOUNT OF FUNDS OR
OTHER CONSIDERATION.

 

This statement relates to Shares in the Issuer
that the Reporting Person has the right to acquire in sixty days. These securities in the Issuer are described as follows:

 



Options in the Issuer for the right to acquire 1,680,000 shares of common at exercise
prices ranging from $0.04 to $0.08 per share.

On December 31, 2010 the Issuer extended a Promissory Note due to the Reporting Person
totaling $179,677.66. Under the terms of the Promissory Note, the Reporting Person has the right to convert all or any part of
the principal sum of the loan into common stock of the Issuer as well as a warrant agreement to purchase one share for every two
shares acquired. The expiration date on the warrant is 3 years from the date of conversion.

On December 31, 2010 the Issuer extended a Promissory Note due to the Reporting Person
totaling $66,686. Under the terms of the Promissory Note, the Reporting Person has the right to convert all or any part of the
principal sum of the loan into common stock of the Issuer as well as a warrant agreement to purchase one share for every two shares
acquired. The expiration date on the warrant is 3 years from the date of conversion.

On December 31, 2010 the Issuer's Board of Directors approved a Debt Converstion Agreement
which grants the Reporting Person the right to convert gross salary debt owed to her totaling $212,322 into common stock of the
Issuer as well as a warrant agreement to purchase one share for every two shares acquired. The expiration date on the warrant is
3 years from the date of conversion.




    
 
    
3
    



ITEM 4.	PURPOSE OF TRANSACTION

 

The purpose of this Schedule 13D is to report
the Beneficial Ownership by the Reporting Person of 22,944,266 shares or 23.85% of the Issuer’s issued and outstanding
common stock as of March 2, 2011.

 

Except as provided below, the Reporting Person
does not have any current plans or proposals which would relate to or would result in:

 

(a) the acquisition by any person of additional
securities of the Issuer, or the disposition of securities of the Issuer;

 

(b) any extraordinary corporate transaction,
such as a merger, reorganization or liquidation, involving the Issuer or any of its subsidiaries;

 

(c) a sale or transfer of a material amount
of the assets of the Issuer or any of its subsidiaries;

 

(d) any change in the present board of directors
or management of the Issuer, including any plans or proposals to change the number or term of directors or to fill any existing
vacancies on the board;

 

(e) any material change in the present capitalization
or dividend policy of the Issuer;

 

(f) any other material change in the Issuer's
business or corporate structure including, but not limited to, if the Issuer is a registered closed-end investment company, any
plans or proposals to make any changes in its investment policy for which a vote is required by Section 13 of the Investment Company
Act of 1940;

 

(g) changes in the Issuer's charter, bylaws
or instruments corresponding thereto or other actions which may impede acquisition of control of the Issuer by any person;

 

(h) causing a class of securities of the Issuer
to be delisted from a national securities exchange or to cease to be authorized to be quoted in an inter-dealer quotation system
of a registered national securities association;

 

(i) a class of equity securities of the Issuer
becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Act; or

 

(j) any action similar to any of those enumerated
above.

 

ITEM 5.	INTEREST IN SECURITIES OF THE
ISSUER.

 

(a)	The Reporting
Person is currently the beneficial owner of 22,944,266 shares of Common Stock of the Issuer, representing approximately
23.85% of the Issuer's common stock (based upon 96,193,259 outstanding shares of common stock as of March 2, 2011.)

 


    
 
    
4
    



(b)	The Reporting
Person has sole voting and dispositive power over the Shares identified in response to Item 5(a) above.

 

(c)	See response
by Reporting Person to Item 4, above.

 

(d)	Not applicable.

 

(e)	Not applicable.

 

ITEM 6.	CONTRACTS,
ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER.

 

Other than as described in this Schedule 13D,
the Reporting Person has no contracts, arrangements, understandings or relationships with any other person with respect to any
securities of the Issuer.

 

ITEM 7.	MATERIAL TO BE FILED AS
EXHIBITS.

 

None.

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement is true, complete and correct.

 

 

Date:	March 2, 2011

 

 

 

By: /s/ Doreen McMorran

Doreen McMorran